SCHEMBL30937588

SCHEMBL30937588

O=C(O)CN1Cc2c(ccnc2Cl)NC1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.48
▸ MMP13 P45452 1/20 0.48
▸ CYP2D6 P10635 3/20 0.35
▸ CYP2C19 P33261 3/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ PTGDR2 Q9Y5Y4 2/20 0.33
▸ DPP4 P27487 1/20 0.33
▸ DPP8 Q6V1X1 1/20 0.33
▸ DPP9 Q86TI2 1/20 0.33
▸ LMNA P02545 2/20 0.33
▸ ITGB1 P05556 1/20 0.32
▸ ITGAV P06756 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937608 0.82 ACE (0.42) ACEMMP13POLBKDM4EMAPK1
SCHEMBL30937632 0.81 ACE (0.40) ACEMMP13LMNAKDM4EMAPK1
SCHEMBL30937665 0.75 ACE (0.47) ACEMMP13CYP2D6CYP2C19CYP2C9
SCHEMBL30937732 0.72 ACE (0.44) ACEMMP13CYP2D6CYP2C19CYP2C9
SCHEMBL30937524 0.72 ACE (0.44) ACEMMP13CYP2D6CYP2C19CYP2C9
SCHEMBL30937651 0.72 ACE (0.53) ACEMMP13CYP2D6CYP2C19CYP2C9
SCHEMBL30937579 0.71 ACE (0.40) ACEMMP13CYP2D6CYP2C19CYP2C9
SCHEMBL31120592 0.70 CA12 (0.37) POLBPTGDR2LMNAKDM4ESMN1; SMN2
SCHEMBL30937681 0.70 ACE (0.42) ACEMMP13CYP2D6CYP2C19CYP2C9
SCHEMBL31120591 0.70 ACE (0.45) ACEMMP13CYP2D6CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback